Public Perceptions of Neuromodulation: Hope, Healing and… Hesitation

A new study by Atkinson-Clement, Junor, and Kaiser (2025) sheds light on how the general public perceives neuromodulation—interventions that directly alter nervous system activity. With 784 participants surveyed across the UK and beyond, the research shows that while neuromodulation is often met with interest and curiosity, concerns about safety and trust remain. Importantly, the simple act of providing information significantly improved people’s optimism and comfort, highlighting the power of education in shaping acceptance of brain-based treatments.

Neuromodulation is a broad umbrella term that includes both invasive approaches, such as brain implants, and non-invasive techniques like transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and ultrasound stimulation. These methods are increasingly being explored as alternatives or complements to traditional pharmaceutical interventions. While biofeedback and neurofeedback are not strictly part of this study’s focus, they belong to the same family of brain-directed interventions and share a common theme: empowering individuals to self-regulate or modify brain function in ways that can improve mental health and well-being.

This article represents emerging research with novel insights into the role of public perception in neuromodulation’s future. If patients distrust a technique, they are less likely to adhere to treatment, which the World Health Organization warns is a leading cause of avoidable poor health outcomes. Understanding how the public views neuromodulation—and how these views can be shifted with better education—is essential for clinicians, policymakers, and innovators developing the next generation of brain-based therapies.

Methods

The study relied on a large-scale online survey designed to capture how non-expert individuals view neuromodulation. A total of 784 participants were recruited through diverse channels, including social media, brain health charities, and mailing lists. While most respondents were based in the UK, the survey reached an international audience.

The questionnaire was structured in four sections:

1. General perception – Participants were presented with a simple definition of neuromodulation and asked to rate their feelings using adjectives (e.g., optimistic, worried, confused).

2. Specific techniques – Respondents received descriptions of five approaches: pharmaceutical drugs, brain implants, electrical stimulation, magnetic stimulation, and ultrasound stimulation. They rated these in terms of safety, effectiveness, and preference if they were to require treatment.

3. Demographics – Standardized questions on age, gender, education, occupation, income, and health status.

4. Condition-specific questions – Additional items for those with neurological or psychiatric diagnoses.

Statistical analyses used advanced models to preserve the non-linear nature of survey responses. Word-mining was also performed on free-text answers, allowing the researchers to link language use (such as “love,” “risky,” or “machine”) with emotional valence.

Results

The findings were striking in several ways:

• Baseline perception: Neuromodulation was mostly associated with interest (+3.01 on a -5 to +5 scale). However, confusion was also common, with nearly half of participants admitting uncertainty about what it meant.

• Impact of information: After being provided with more detail, participants reported significant increases in optimism (+1.64), comfort (+1.10), and excitement (+0.53). Confusion declined sharply (−1.21), showing the power of education. A slight rise in worry (+0.18) and anger (+0.05) suggested some lingering unease.

• Ranking of methods: Ultrasound stimulation emerged as the top choice (67% placing it first or second), followed by magnetic stimulation (50%). Drugs (36%) and electrical stimulation (32%) were mid-ranked, while brain implants came last (14%), largely due to safety concerns.

• Safety and effectiveness perceptions: Ultrasound and magnetic stimulation were considered safest, while drugs and implants were viewed as risky. Interestingly, brain implants were rated as highly effective but also least safe—a key reason for their low preference.

• Subgroup differences: Younger participants tended to prefer drugs, while females leaned toward ultrasound. Otherwise, preferences were consistent across demographic and clinical groups.

Discussion

This research highlights the central role of public perception in the future of neuromodulation. Three insights stand out:

1. Information matters: Confusion is common, but it is not fixed. Providing clear, balanced information improved optimism, comfort, and excitement while reducing uncertainty. This suggests that education is a powerful lever for improving adherence and trust.

2. Safety concerns drive preferences: Even when considered effective, invasive options such as implants lose out to non-invasive techniques because of perceived risk. This finding aligns with broader healthcare trends where patients prefer therapies that are less invasive and carry fewer side effects.

3. Implications for clinical practice: For clinicians, these findings emphasize the importance of framing treatments not only in terms of efficacy but also safety and transparency. Even if an option like deep brain stimulation is clinically indicated, success may hinge on whether patients trust and understand it.

More broadly, this study underscores how treatment adherence—already known to be fragile—can be improved by aligning interventions with patient preferences and priorities. The data show that if neuromodulation is to be embraced widely, it must be presented in ways that resonate with both clinical realities and public comfort.

Brendan’s Perspective

As someone deeply engaged in neurofeedback practice, I find these findings illuminating. What strikes me most is the public’s preference for non-invasive neuromodulation. Ultrasound and magnetic stimulation are seen as promising precisely because they don’t involve surgery or implants. Still, I consider them to be invasive as they actively induce modulations brain activity, sometimes with undesirable side-effects. This is where neurofeedback has a clear advantage, not only scientifically but also perceptually.

Unlike passive neuromodulation—where something is “done to” the brain—neurofeedback is an active learning process. Much like in psychotherapy, the individual is not a passive recipient of change but an active participant. The brain learns to regulate itself through feedback and practice, building skills that can persist long after the training ends. This is very different from pharmacological approaches, which work only as long as the drug is taken, or even from stimulation techniques that externally drive brain activity.

From a clinical perspective, this active engagement translates into deeper neuroplastic changes. Protocols such as sensorimotor rhythm (SMR) training for self-control or alpha enhancement for relaxation build capacities that clients can carry into their daily lives. These changes are not imposed; they are learned, integrated, and sustained.

From a public perception standpoint, neurofeedback should be well-positioned. It is non-invasive, empowering, and aligned with people’s natural preference for safe and durable treatments. However, this advantage depends heavily on how it is communicated. The same study reminds us that without adequate information, people may default to confusion or skepticism. Our responsibility as practitioners is to frame neurofeedback as both scientifically grounded and deeply human—a way for individuals to partner with their own brains.

If presented properly, neurofeedback could stand not just as another form of neuromodulation, but as the one that resonates most strongly with the public’s hopes: effective, safe, and enduring. I would love to see this study replicated with neurofeedback added to the mix. 

Conclusion

The study by Atkinson-Clement and colleagues highlights how the public perceives neuromodulation and the powerful role of education in shaping acceptance. Overall, people are open and interested, especially when techniques are non-invasive and clearly explained. Ultrasound stimulation currently leads in public preference, but the findings also point toward an important lesson for the field: trust and adherence grow when interventions are safe, transparent, and empowering.

For neurofeedback practitioners and advocates, this is an encouraging message. Non-invasive, active, and skill-based approaches may not only offer scientific advantages but also align with what the public most wants from brain-based treatments. In the end, the future of neuromodulation will depend not just on what works in the lab, but on what people feel comfortable embracing in their lives.

References

Atkinson-Clement, C., Junor, A., & Kaiser, M. (2025). Neuromodulation perception by the general public. Scientific Reports, 15(5584). https://doi.org/10.1038/s41598-025-89437-8